Physician
Ophthalmic Consultants of Long Island
Ophthalmic Consultants of Long Island was paid $7.83M by Medicaid between Jan 2018 and Dec 2024, across 36 billing codes. Its largest line is 92014, Ophthalmological services: medical examination and evaluation, comprehensive, established patient — 35% of everything it billed.
33Billing provider infoOPHTHALMIC CONSULTANTS OF LONG ISLAND
ROCKVILLE CENTRE, NY 11570
ROCKVILLE CENTRE, NY 11570
33aNPI1285675660assigned 06/09/2006
33bProvider typeOphthalmology Physician
28Total paid$7.83M
24GClaims120,816
24DCodes billed36
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Ophthalmology Physician providers in New York
Rank by total paid#7 of 1,085
Median peer was paid$34K
This provider vs. median231×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 1,201 | $57K | |
| 2019 | 1,756 | $102K | |
| 2020 | 2,736 | $183K | |
| 2021 | 9,144 | $660K | |
| 2022 | 22,848 | $1.61M | |
| 2023 | 47,487 | $3.08M | |
| 2024incomplete | 35,644 | $2.13M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | 35% | 26,817 | 26,750 | $2.71M |
| 92004 | Ophthalmological services: medical examination and evaluation, comprehensive, new patient | 14% | 8,179 | 8,176 | $1.08M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 9.0% | 9,420 | 8,958 | $705K |
| J0178 | Injection, aflibercept, 1 mg | 7.4% | 426 | 372 | $583K |
| 92012 | Ophthalmological services: medical examination and evaluation, intermediate, established patient | 5.5% | 6,789 | 6,558 | $428K |
| 67028 | Intravitreal injection of a pharmacologic agent | 4.7% | 3,644 | 3,457 | $370K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 4.3% | 3,912 | 3,843 | $333K |
| 92134 | 3.8% | 9,854 | 9,598 | $296K | |
| 92250 | 3.4% | 8,426 | 8,403 | $270K | |
| 92083 | 2.4% | 3,654 | 3,646 | $185K | |
| 92235 | 2.0% | 1,519 | 1,516 | $158K | |
| 92015 | Determination of refractive state | 2.0% | 24,559 | 24,489 | $155K |
24 more codes
| 92133 | 1.3% | 3,420 | $100K | |
| J9035 | Injection, bevacizumab, 10 mg | 1.2% | 1,551 | $94K |
| 92020 | <1% | 2,854 | $64K | |
| 66984 | Extracapsular cataract removal with insertion of intraocular lens prosthesis | <1% | 180 | $63K |
| 68761 | <1% | 341 | $43K | |
| 67228 | <1% | 131 | $35K | |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 220 | $29K |
| 92060 | <1% | 492 | $25K | |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 265 | $24K |
| 92136 | <1% | 496 | $17K | |
| 92202 | <1% | 1,215 | $15K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 137 | $14K |
| 83861 | <1% | 1,019 | $10K | |
| 92025 | <1% | 392 | $10K | |
| 92285 | <1% | 259 | $3K | |
| 92273 | <1% | 24 | $2K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 44 | $2K |
| 76514 | <1% | 221 | $2K | |
| 92201 | <1% | 99 | $2K | |
| 92002 | <1% | 14 | $1K | |
| V2100 | Sphere, single vision, plano to plus or minus 4.00, per lens | <1% | 38 | $846.24 |
| V2020 | Frames, purchases | <1% | 57 | $843.45 |
| 2022F | 0% | 136 | $0.00 | |
| 92145 | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialBURKE, THOMAS (CEO)
| Provider | Location | Paid |
|---|---|---|
| Clara Maass Medical Center | Belleville, NJ | $156.84M |
| Burke Dermatology, PA | Newark, DE | $2.38M |
| Neurotech, Na INC. | Manassas, VA | $1.33M |
| Lehigh Valley Eye Center, P.C. | Allentown, PA | $957K |
| Ophthalmic Consultants of Long Island | Stony Brook, NY | $193K |
| Boston Orthopaedic and Spine LLC | Brighton, MA | $2K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.